{"id":344711,"date":"2026-11-12T13:14:30","date_gmt":"2026-11-12T07:44:30","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/kwality-pharmaceuticals-q2-results-fy27-pat-29-crore\/"},"modified":"2026-11-12T13:14:30","modified_gmt":"2026-11-12T07:44:30","slug":"kwality-pharmaceuticals-q2-results-fy27-pat-29-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/kwality-pharmaceuticals-q2-results-fy27-pat-29-crore\/","title":{"rendered":"Kwality Pharmaceuticals Q2 Results FY27: PAT Jumps 105.59% to Rs 29.03 Cr, Revenue Rs 181.22 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Kwality Pharmaceuticals Q2 Results FY27 were declared on 12 November 2026 on a consolidated basis. The quarterly results show revenue of Rs 181.22 Cr, up 63.19% from Rs 111.05 Cr a year earlier. Net profit stood at Rs 29.03 Cr against Rs 14.12 Cr, a YoY growth of 105.59%, while Operating Profit rose 96.45% to Rs 49.8 Cr.<\/p>\n<\/div>\n

Kwality Pharmaceuticals Ltd<\/a> (KPL) Q2 Results FY27 announced on 12 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought Consolidated revenue of Rs 181.22 Cr and PAT of Rs 29.03 Cr. Kwality Pharmaceuticals Q2 Results FY27 therefore point to a year on year rise in both lines, and these consolidated results are unpacked below.<\/p>\n

This results analysis covers the financial highlights, business drivers, outlook and risks behind Kwality Pharmaceuticals Q2 Results. Univest tracks these figures so readers can compare them quickly, and the table that follows sets out each metric against the same quarter last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n